BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 15877292)

  • 1. Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats.
    Jia D; Taguchi M; Otsuki M
    Metabolism; 2005 May; 54(5):619-27. PubMed ID: 15877292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
    Jia D; Taguchi M; Otsuki M
    Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats.
    Jia D; Yamamoto M; Otani M; Otsuki M
    Metabolism; 2004 Apr; 53(4):405-13. PubMed ID: 15045684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by alpha-glucosidase inhibitor.
    Yamamoto M; Jia DM; Fukumitsu KI; Imoto I; Kihara Y; Hirohata Y; Otsuki M
    Metabolism; 1999 Mar; 48(3):347-54. PubMed ID: 10094112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
    Jia DM; Tabaru A; Nakamura H; Fukumitsu KI; Akiyama T; Otsuki M
    Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats.
    Fukaya N; Mochizuki K; Tanaka Y; Kumazawa T; Jiuxin Z; Fuchigami M; Goda T
    Eur J Pharmacol; 2009 Dec; 624(1-3):51-7. PubMed ID: 19818342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bezafibrate, a peroxisome proliferator-activated receptor (PPAR)-alpha activator, prevents pancreatic degeneration in obese and diabetic rats.
    Jia D; Otsuki M
    Pancreas; 2003 Apr; 26(3):286-91. PubMed ID: 12657956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of camostat, a synthetic protease inhibitor, on endocrine and exocrine pancreas of the rat.
    Müller MK; Goebell H; Alfen R; Ehlers J; Jäger M; Plümpe H
    J Nutr; 1988 May; 118(5):645-50. PubMed ID: 2452864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in islet capillary angioarchitecture coincide with impaired B-cell function but not with insulin resistance in male Otsuka-Long-Evans-Tokushima fatty rats: dimorphism of the diabetic phenotype at an advanced age.
    Mizuno A; Noma Y; Kuwajima M; Murakami T; Zhu M; Shima K
    Metabolism; 1999 Apr; 48(4):477-83. PubMed ID: 10206441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of timely insulin administration on pancreatic B-cells of Otsuka-Long-Evans-Tokushima-Fatty (OLETF) strain rats. An animal model of non-insulin dependent diabetes mellitus (NIDDM).
    Ishida K; Mizuno A; Sano T; Noma Y; Shima K
    Horm Metab Res; 1995 Sep; 27(9):398-402. PubMed ID: 8557237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare sugar D-psicose protects pancreas β-islets and thus improves insulin resistance in OLETF rats.
    Hossain A; Yamaguchi F; Matsunaga T; Hirata Y; Kamitori K; Dong Y; Sui L; Tsukamoto I; Ueno M; Tokuda M
    Biochem Biophys Res Commun; 2012 Sep; 425(4):717-23. PubMed ID: 22877751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diazoxide prevents abdominal adiposity and fatty liver in obese OLETF rats at prediabetic stage.
    Guo Z; Bu S; Yu Y; Ghatnekar G; Wang M; Chen L; Bu M; Yang L; Zhu B; Feng Z; Huang Q
    J Diabetes Complications; 2008; 22(1):46-55. PubMed ID: 18191077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of insulin and glucagon secretion from the perfused pancreas before, at the onset and after the development of diabetes in male Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Kanazawa M; Tanaka A; Nomoto S; Shirabe S; Hukuda G; Arai K; Notoya Y; Hayashi T; Komeda K; Kanazawa Y
    Diabetes Res Clin Pract; 1997 Dec; 38(3):161-7. PubMed ID: 9483381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Hossain MA; Kitagaki S; Nakano D; Nishiyama A; Funamoto Y; Matsunaga T; Tsukamoto I; Yamaguchi F; Kamitori K; Dong Y; Hirata Y; Murao K; Toyoda Y; Tokuda M
    Biochem Biophys Res Commun; 2011 Feb; 405(1):7-12. PubMed ID: 21187061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary β-Conglycinin Modulates Insulin Sensitivity, Body Fat Mass, and Lipid Metabolism in Obese Otsuka Long-Evans Tokushima Fatty (OLETF) Rats.
    Kawabeta K; Hase-Tamaru S; Yuasa M; Suruga K; Sugano M; Koba K
    J Oleo Sci; 2019 Apr; 68(4):339-350. PubMed ID: 30867392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of obesity and inheritance on the development of non-insulin-dependent diabetes mellitus in Otsuka-Long-Evans-Tokushima fatty rats.
    Okauchi N; Mizuno A; Zhu M; Ishida K; Sano T; Noma Y; Shima K
    Diabetes Res Clin Pract; 1995 Jul; 29(1):1-10. PubMed ID: 8593753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inhibition of alpha-glucosidase on age-related glucose intolerance and pancreatic atrophy in rats.
    Yamamoto M; Otsuki M
    Metabolism; 2006 Apr; 55(4):533-40. PubMed ID: 16546485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with atorvastatin attenuates progression of insulin resistance and pancreatic fibrosis in the Otsuka Long-Evans Tokushima fatty rats.
    Wei L; Yamamoto M; Harada M; Otsuki M
    Metabolism; 2016 Feb; 65(2):41-53. PubMed ID: 26773928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of proteinase inhibitor camostat on exocrine pancreas in fed and fasted rats.
    Otsuki M; Tani S; Fujii M; Nakamura T; Okabayashi Y; Koide M
    Am J Physiol; 1993 Oct; 265(4 Pt 2):R896-901. PubMed ID: 7694489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats.
    Rodriguez R; Minas JN; Vazquez-Medina JP; Nakano D; Parkes DG; Nishiyama A; Ortiz RM
    J Endocrinol; 2018 Jun; 237(3):271-284. PubMed ID: 29643115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.